REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,310,448 | -62.6% | 114,250 | -17.6% | 0.00% | -76.9% |
Q2 2023 | $3,507,890 | +105.4% | 138,597 | +161.4% | 0.01% | +85.7% |
Q1 2023 | $1,707,806 | -34.8% | 53,021 | -62.6% | 0.01% | -50.0% |
Q4 2022 | $2,619,105 | +238.4% | 141,880 | +394.9% | 0.01% | +180.0% |
Q3 2022 | $774,000 | +11.4% | 28,669 | +22.3% | 0.01% | -37.5% |
Q2 2021 | $695,000 | +92.5% | 23,435 | +63.3% | 0.01% | +60.0% |
Q3 2020 | $361,000 | +12.8% | 14,353 | +9.4% | 0.01% | 0.0% |
Q2 2020 | $320,000 | – | 13,117 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |